artículo
Design, Synthesis, In Silico Studies and Inhibitory Activity towards Bcr-Abl, BTK and FLT3-ITD of New 2,6,9-Trisubstituted Purine Derivatives as Potential Agents for the Treatment of Leukaemia
link https://doi.org/10.3390/pharmaceutics14061294Datos investigador
account_box Jeanluc Bertrandaccount_box Hana Dostálováaccount_box Vladimir Krystofaccount_box Radek Jordaaccount_box Thalía Delgadoaccount_box Alejandro Castro-Alvarezaccount_box jaime mellaaccount_box David Cabezasaccount_box Mario Faúndezaccount_box Christian Espinosa-Bustosaccount_box Salas Sanchez, Cristian Osvaldo
account_box Jeanluc Bertrandaccount_box Hana Dostálováaccount_box Vladimir Krystofaccount_box Radek Jordaaccount_box Thalía Delgadoaccount_box Alejandro Castro-Alvarezaccount_box jaime mellaaccount_box David Cabezasaccount_box Mario Faúndezaccount_box Christian Espinosa-Bustosaccount_box Salas Sanchez, Cristian Osvaldo
Altmetric
Comparte este registro
Registro Sencillo
Registro Completo
| Autor | Jeanluc Bertrand Hana Dostálová Vladimir Krystof Radek Jorda Thalía Delgado Alejandro Castro-Alvarez jaime mella David Cabezas Mario Faúndez Christian Espinosa-Bustos Salas Sanchez, Cristian Osvaldo |
| Título | Design, Synthesis, In Silico Studies and Inhibitory Activity towards Bcr-Abl, BTK and FLT3-ITD of New 2,6,9-Trisubstituted Purine Derivatives as Potential Agents for the Treatment of Leukaemia |
| Fecha de publicación | 2022 |
| Derechos | acceso abierto |
| DOI | 10.3390/pharmaceutics14061294 |
| Enlace | https://doi.org/10.3390/pharmaceutics14061294 |
| Id de publicación en WoS | WOS:000816420600001 |
| Tema ODS | 03 Good health and well-being |
| Tema ODS español | 03 Salud y bienestar |
| Tipo de documento | artículo |